Clinical Trials Directory

Trials / Unknown

UnknownNCT04584606

Ain Shams University Experience: Clinical Determinants of Hospitalized COVID-19 Patients

Ain Shams University Experience: Clinical Characteristics and Outcome Determinants of Hospitalized Covid-19 Patients at Ain Shams University Obour Hospital

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

COVID-19 as a novel disease, different disease patterns were observed worldwide, and many treatment plans were tried. So, it is important to investigate the Egyptian clinical characteristics and different factors that determine the patient's 'outcome

Detailed description

Investigators will convey the Ain Shams University experience as the first university in Egypt to designate one of its hospitals (Ain Shams University Obour Hospital) for management of confirmed COVID19 cases. investigators will try to identify the characteristics of the disease as regards the clinical, laboratory and imaging abnormalities and to assess the outcome determinants. It is a retrospective observational cohort study at Ain Shams University Obour Hospital. All adult patients from both sexes with positive nucleic acid testing for severe adult respiratory syndrome Coronavirus (SARS-CoV-2)will be included. Clinical criteria, laboratory data, radiological findings, hospital course and patient outcome will be anonymously collected from records.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLab workup (on admission and regularly during follow up).Complete blood count with differential leucocytic count. Absolute lymphocytic and neutrophilic count. Liver functions: Aspartate transaminase and Alanine transaminase . Renal functions: Blood urea nitrogen, serum Creatinine. HbA1C. C-reactive protein (quantitative). Serum ferritin level. D - dimer level (quantitative). Coagulation profile (Prothrombin time/ Partial thromboplastin time/ International normalized ratio). Troponin level. Arterial blood gases when needed.

Timeline

Start date
2020-06-27
Primary completion
2020-10-31
Completion
2020-12-30
First posted
2020-10-14
Last updated
2020-10-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04584606. Inclusion in this directory is not an endorsement.